1. Home
  2. TRUP vs ARQT Comparison

TRUP vs ARQT Comparison

Compare TRUP & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUP
  • ARQT
  • Stock Information
  • Founded
  • TRUP 2000
  • ARQT 2016
  • Country
  • TRUP United States
  • ARQT United States
  • Employees
  • TRUP N/A
  • ARQT N/A
  • Industry
  • TRUP Medical Specialities
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRUP Health Care
  • ARQT Health Care
  • Exchange
  • TRUP Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • TRUP 2.1B
  • ARQT 1.7B
  • IPO Year
  • TRUP 2014
  • ARQT 2020
  • Fundamental
  • Price
  • TRUP $55.15
  • ARQT $13.74
  • Analyst Decision
  • TRUP Buy
  • ARQT Strong Buy
  • Analyst Count
  • TRUP 6
  • ARQT 6
  • Target Price
  • TRUP $51.80
  • ARQT $18.80
  • AVG Volume (30 Days)
  • TRUP 514.5K
  • ARQT 1.9M
  • Earning Date
  • TRUP 08-07-2025
  • ARQT 08-13-2025
  • Dividend Yield
  • TRUP N/A
  • ARQT N/A
  • EPS Growth
  • TRUP N/A
  • ARQT N/A
  • EPS
  • TRUP N/A
  • ARQT N/A
  • Revenue
  • TRUP $1,321,538,000.00
  • ARQT $212,819,000.00
  • Revenue This Year
  • TRUP $11.30
  • ARQT $61.15
  • Revenue Next Year
  • TRUP $6.01
  • ARQT $37.98
  • P/E Ratio
  • TRUP N/A
  • ARQT N/A
  • Revenue Growth
  • TRUP 14.08
  • ARQT 100.03
  • 52 Week Low
  • TRUP $26.96
  • ARQT $7.86
  • 52 Week High
  • TRUP $57.90
  • ARQT $17.75
  • Technical
  • Relative Strength Index (RSI)
  • TRUP 71.93
  • ARQT 56.81
  • Support Level
  • TRUP $54.58
  • ARQT $13.97
  • Resistance Level
  • TRUP $57.34
  • ARQT $14.69
  • Average True Range (ATR)
  • TRUP 1.94
  • ARQT 0.66
  • MACD
  • TRUP 0.20
  • ARQT 0.12
  • Stochastic Oscillator
  • TRUP 86.50
  • ARQT 78.87

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: